Diabetes-Resistant NOR Mice Are More Severely Affected by Streptozotocin Compared to the Diabetes-Prone NOD Mice: Correlations with Liver and Kidney GLUT2 Expressions

<div>GLUT2 immunohistochemistry stainings in NOD and NOR islets. Representative islet images are shown demonstrating GLUT2 expression levels prior to (day 0) and after STZ application (days 4 and 7). Hematoxylin counterstaining was performed following anti-GLUT2 antibody application. Tissues depicted as “control” were treated with secondary antibody only.</div>

Journal of Diabetes Research

fig4

Figure 4

Figure 4: Diabetes-Resistant NOR Mice Are More Severely Affected by Streptozotocin Compared to the Diabetes-Prone NOD Mice: Correlations with Liver and Kidney GLUT2 Expressions 

Figure 4 | Diabetes-Resistant NOR Mice Are More Severely Affected by Streptozotocin Compared to the Diabetes-Prone NOD Mice: Correlations with Liver and Kidney GLUT2 Expressions 